Cargando…
Dendrimers and Derivatives as Multifunctional Nanotherapeutics for Alzheimer’s Disease
Alzheimer’s disease (AD) is the most prevalent form of dementia. It affects more than 30 million people worldwide and costs over US$ 1.3 trillion annually. AD is characterized by the brain accumulation of amyloid β peptide in fibrillar structures and the accumulation of hyperphosphorylated tau aggre...
Autores principales: | Moreira, Débora A., Santos, Sofia D., Leiro, Victoria, Pêgo, Ana P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140951/ https://www.ncbi.nlm.nih.gov/pubmed/37111540 http://dx.doi.org/10.3390/pharmaceutics15041054 |
Ejemplares similares
-
Multifunctional Nanotherapeutics for the Treatment of neuroAIDS in Drug Abusers
por: Jayant, Rahul Dev, et al.
Publicado: (2018) -
Nanotherapeutics for treating coronavirus diseases
por: Gunathilake, Thennakoon M. Sampath U., et al.
Publicado: (2021) -
Breaking Barriers: Bioinspired Strategies for Targeted Neuronal Delivery to the Central Nervous System
por: Spencer, Ana P., et al.
Publicado: (2020) -
Extracellular Vesicles as Nanotherapeutics for Parkinson’s Disease
por: Leggio, Loredana, et al.
Publicado: (2020) -
Brain Delivery of Multifunctional Dendrimer Protein Bioconjugates
por: Moscariello, Pierpaolo, et al.
Publicado: (2018)